Primary study · included by 1 review
A phase 2 study evaluating the efficacy and safety of a novel, proprietary, nano-formulated, lower dose oral diclofenac.
Manvelian 2012 · Manvelian Garen, Daniels Stephen, Gibofsky Allan · Pain medicine (Malden, Mass.) · 2012
Included by
The review does not say which of its outcomes this study informs.
1 including review in total.